CMS Pharmacology Proctored Comprehensive Examination
Core Domains: Drug Classifications & Mechanisms of Action, Medication Administration & Safety,
Pharmacokinetics (Absorption, Distribution, Metabolism, Excretion), Pharmacodynamics, Adverse
Effects & Contraindications, Drug Interactions, Dosage Calculations, Patient Education & Adherence,
and Legal/Ethical Considerations in Medication Management | Nursing Education & NCLEX-RN®
Focus
Exam Structure
The CMS Pharmacology Proctored Exam for the 2026/2027 testing cycle is a comprehensive, 60-question
proctored assessment designed to evaluate mastery of pharmacological principles and safe medication
practices across all body systems and patient populations.
Introduction
This CMS Pharmacology Proctored Exam guide for the 2026/2027 academic year provides actual exam
questions and verified answers for comprehensive preparation. It emphasizes the integration of
pharmacological science with clinical nursing practice, requiring students to understand drug actions,
anticipate adverse effects, perform accurate calculations, and provide essential patient education to
ensure safe, effective medication administration.
Answer Format
All correct medication selections, nursing interventions, and safety-critical information must be presented
in bold and green, followed by detailed rationales that link drug properties to patient conditions,
highlight monitoring priorities, and reinforce medication safety protocols based on evidence-based
pharmacology.
60 Multiple Choice Questions (MCQ)
1. Drug Classifications & Mechanisms of Action
1. Which of the following drug classes is used to treat hypertension by blocking angiotensin
II receptors?
A. ACE inhibitors
B. ARBs (Angiotensin II Receptor Blockers)
C. Beta blockers
, D. Calcium channel blockers
B. ARBs (Angiotensin II Receptor Blockers)
ARBs block angiotensin II receptors, preventing vasoconstriction and aldosterone release, which lowers
blood pressure.
2. Which of the following is the mechanism of action of beta blockers?
A. Block calcium channels in cardiac and vascular smooth muscle
B. Inhibit the conversion of angiotensin I to angiotensin II
C. Block beta-adrenergic receptors, reducing heart rate and contractility
D. Increase sodium and water excretion by the kidneys
C. Block beta-adrenergic receptors, reducing heart rate and contractility
Beta blockers reduce heart rate and contractility by blocking beta-adrenergic receptors, decreasing
cardiac workload and oxygen demand.
3. Which of the following drug classes is used to reduce cholesterol levels by inhibiting
HMG-CoA reductase?
A. Fibrates
B. Statins
C. Bile acid sequestrants
D. Niacin
B. Statins
Statins inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, reducing LDL
cholesterol levels.
, 4. Which of the following is the primary mechanism of action of diuretics?
A. Increase sodium and water reabsorption
B. Promote sodium and water excretion
C. Block angiotensin II receptors
D. Inhibit the renin-angiotensin-aldosterone system
B. Promote sodium and water excretion
Diuretics promote the excretion of sodium and water, reducing blood volume and lowering blood
pressure.
5. Which of the following drug classes is used to treat type 2 diabetes by increasing insulin
sensitivity?
A. Sulfonylureas
B. Biguanides (e.g., Metformin)
C. Thiazolidinediones
D. DPP-4 inhibitors
C. Thiazolidinediones
Thiazolidinediones increase insulin sensitivity in peripheral tissues, improving glucose uptake and
utilization.
2. Medication Administration & Safety
6. Which of the following is the most appropriate route for administering insulin?
A. Oral
B. Subcutaneous